Investors are pouring a significant amount of capital into the field of artificial intelligence; in April of this year, Alphasense raised $100 million from Alphabet-C parent company Alphabet-C and other companies.
According to the information obtained by Zhītōng Finance APP, market research and data analysis company Alphasense Inc., which is based on artificial intelligence technology, is currently undergoing financing, and the valuation of this start-up company has reached as high as $2.5 billion. Informed sources said that the New York-based company is currently in talks to raise approximately $150 million, which will be used to fund growth opportunities, including potential acquisition projects. The negotiations for this round of financing have not yet concluded, and the results may be announced within a few weeks. A representative from Alphasense declined to comment.
This round of financing comes at a time when global investors are pouring large amounts of money into artificial intelligence-related technology companies, as investors are investing heavily in the field of artificial intelligence. Earlier this year, Microsoft (MSFT.US) invested as much as $10 billion in OpenAI, the parent company of OpenAI. Global investment institutions and billionaires have been pouring large amounts of money into this field, betting that artificial intelligence will become the next rapidly expanding technology field, with the potential to disrupt everything from art to finance.
According to a statement, in April of this year, Alphasense raised $100 million from investors such as Viking Global Investors, Google's parent company Alphabet (GOOGL.US), and Wall Street financial giant Goldman Sachs Group (GS.US) at a valuation of $1.8 billion.
According to the Alphasense website, the company was founded in 2011 and uses artificial intelligence to collect and share corporate documents, stock reports, news, and other data for its market research platform. Its "AI-based search engine" is used to help cancer researchers understand the latest developments in clinical trials and assist consultants in various industries in generating new business ideas. According to official website information, the platform of this start-up company aggregates over 10,000 data sources, including corporate documents, research reports, industry news, and regulatory documents.
It is understood that the clients of this start-up company cover almost all major Wall Street commercial banks, including Goldman Sachs, JPMorgan Chase (JPM.US), Wells Fargo (WFC.US), and Bain Capital.
The official website of the company also shows that 85 companies in the S&P 100 Index, one of the benchmark stock indices in the U.S., are part of its client base, covering not only Wall Street financial giants such as Goldman Sachs, JPMorgan Chase, Wells Fargo, and Bernstein, but also top leaders in various industries such as Google, Microsoft, and Siemens, serving over 4,000 companies in various industries.
